Navigation Links
Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium
Date:4/8/2008

TAMPA, Fla., April 8, 2008 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today the presentation of data from two Phase 3 clinical trials of Durezol(TM) (difluprednate ophthalmic emulsion) 0.05%, a topical steroid in the treatment of postoperative ocular inflammation. The results were given in a presentation by Michael Korenfeld, MD during the American Society of Cataract and Refractive Surgery Annual Symposium in Chicago, Illinois.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO )

The two multi-center studies evaluated the safety and efficacy of Durezol(TM) 0.05% compared to placebo dosed twice a day (BID) and four times a day (QID) beginning 24 hours after ocular surgery. The studies included 438 subjects who presented with an anterior chamber cell grade 2 (greater than or equal to 10 cells) or higher the day after surgery. The clinically and statistically significant findings demonstrated that Durezol(TM), at both the BID and QID dosing regimens, was superior to placebo in achieving the primary endpoint of proportion of subjects with an anterior chamber cell grade of 0 (less than or equal to 1 cell) on Day 8, with 30% of subjects in the BID group reaching Grade 0 versus 9% in the placebo group. Of the subjects in the QID group, 35% reached Grade 0 on Day 8. In addition, Durezol(TM) maintained superiority over placebo through the treatment period (Day 15), with 56% in the BID group and 63% in the QID group reaching Grade 0 versus 16% in the placebo group.

Further data from the presentation demonstrated that both the BID and QID dosing regimens were superior to placebo with regard to change from baseline in anterior chamber cell count at Day 8. The mean reduction in cell count for subjects in both the BID and QID groups was 19 cells and the mean reduction in the placebo gr
'/>"/>

SOURCE Sirion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
2. Sirion Therapeutics Supports Ophthalmic Education
3. Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
4. Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
5. DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
6. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
7. Mercury Therapeutics Patents Filed
8. Cell Therapeutics, Inc. Announces Filing of Form 10-K
9. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference
10. TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights
11. Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )w...ecember1stat1:45PMGMTinLondon,7:45AMUS/CST.Interes...ernetavailableat http://inve s tor.sig m a a...essthisfile. ,, AboutSigma-Aldrich: Sigma-Al....Itschemicalandbiochemicalproductsandkitsareusedin...
(Date:11/24/2009)...ia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood&...gationalnewdrugapplication(IND)foritsoralinsulinpr...atdiabetes.ThisIND,approvalallowsBiolaxytoinitiate...ordercharacteristicofhighbloodglucoseandpoor,metab...emicro-and,macro-vasculardiseases,lossofvision,kid...
(Date:11/24/2009)...FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theg...ncedthatithassubmittedaMAAtotheEuropeanMedicinesAg...ementtherapyindevelopment,forthetreatmentofType1Ga...rvelaglucerasealfathathasbeensubmitted,withpreviou...sedonaglobalsupplyshortageofthecurrentlyapprovedan...
(Date:11/24/2009)...stracts Service (CAS), the global expert on chemic... is now the world,s leading producer of patent inv...pan,s patent office, the World Intellectual Proper...nt and Trademark Office (USPTO) for more than a de...and exceeded Japan for the first time on a monthly...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
..., , , , , For cleanup of DNA f... , , , Applicati... , , Format: , S...roughput: , 124 samples, , ...100 bp 10 kb, , , ...
..., , , , , For purification of ... , , , Applicatio..., , , Format: , ... Throughput: , 124 samples, ... 70 bp 4 kb*, , , ...
... , , , , , Ni-NTA Superflow ...s-tagged , protein preparations to be perfo...kstation. Using cleared lysates from bacterial cul...rotein per column can be purified under native or ...protocols. The increase in yield means that , ...
Other Biology Technology:Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 2Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 3Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 4
(Date:11/23/2009)...y-associated strain of the deadly superbug MRSAan ...n antibioticsposes a far greater health threat tha...itals, according to a study in the December issue ...reat is easily picked up in fitness centers, schoo...overall burden of MRSA within hospitals, the repor...
(Date:11/23/2009)...0 participants gathered this week for the seventh ...conference. This year,s topic, "Synthetic Biology,...cal researchers to explore the engineering, scient...ield of synthetic biology. , Bonnie L. Bassler, ...sity and this year,s conference chair, challenged ...
(Date:11/23/2009)...ng some of the highest resolution images of peptid...a deeper understanding how biomolecules manipulate...new treatment for kidney stones using biomolecules...nline edition of the journal Proceedings of the N...s interact with mineral surfaces by accelerating, ...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Moms to be warned over use of fetal heart rate monitors 54954 1Type 1 diabetes linked to immune response to wheat 54951 1Type 1 diabetes linked to immune response to wheat 54951 2MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 1MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 2MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 3
...r brains when we learn and remember" Are memories ... an inscription permanently on a clay tablet" Pro...urobiology Department, and his colleagues are chal...he process of storing long-term memories is much m...ne that must run constantly to keep memories going...
...ng out to start a family of their own, members of ... a relative raise their young. Now, researchers re...istic tendencies are most common among species tha...n year is virtually impossible to predict. The fin...nt Biology, a publication of Cell Press. , When t...
...ng having kids to help raise the offspring of othe...e, but many African starlings have adopted this st...heir savanna habitats, according to a new study by...niversity biologists. It appears in the Aug. 21 is...or, called cooperative breeding, is typical of man...
Other Biology News:Memory machine 2Uncertainty drives the evolution of 'cooperative breeding' in birds 2Savanna habitat drives birds, and perhaps others, to cooperative breeding 2Savanna habitat drives birds, and perhaps others, to cooperative breeding 3Savanna habitat drives birds, and perhaps others, to cooperative breeding 4
...T-loxP template is designed to allow kanamycin/ne...ls, respectively. It combines a prokaryotic promo...n E.coli with a eukaryotic promoter (PGK) for ex.... The prokaryotic promoter gb2 is a slightly modi...
...PYREX Fernbach-style culture flask is designed for...a to volume ratio. It can also be used in serum pr...es to achieve maximal oxygen transfer to culture m...and accepts cotton plugs or No. 13 rubber stoppers...
...provides a simple and efficient means for isolatio...exin V magnetic beads (MagBeads). Annexin V is a C...gh affinity for phosphatidylseri The Apoptotic Ce...eans for isolation of apoptotic cells or removal o...
...meter, 7 inch long PYREX NMR tubes are made from q...round joints, valves, and vacuum racks. They are d...300 to 500MHz. They have an O.D. of 4.97 + 0.000-0...NMR tubes can be used with the PYREX Microcell sys...
Biology Products: